FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On September 17, 2007
Docket # Title
1978N-0038 Sunscreen Drug Products
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999D-2013 Cooperative Manufacturing Arrangements for Licensed
2004D-0002 Guidance for Industry and FDA Staff; Saline, Silicone Gel, and Alternative Breast Implants
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
2006P-0487 Health Claim Petition: Isomaltulose and Dental Caries
2007D-0201 Guidance for Industry and Food and Drug Administration Staff; Premarket Notification (510(k)) Submissions for Medical Devices That Include Antimicrobial Agents
2007D-0223 Guidance for Industry on Use of the Computer Crossmatch
2007D-0233 Guidance for Industry on Integrated Summaries of Effectiveness and Safety: Location Within the Common Technical Document
2007D-0268 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
2007N-0179 Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges; Public Workshop
2007N-0186 Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary
2007N-0231 Agency Information Collection Activities; Proposed Collection; Comment Request; Pre-market Approval of Medical Devices
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
2007P-0282 Require all products labels to include this information: Products % Costs Packaging: 80% Content: 20%
2007P-0297 Request to reconsider the failure to approve Provenge
1978N-0038 Sunscreen Drug Products
EC 2388 Mr. Ilan Gutherz Vol #: 161
EC 2389 Ms. Marjorie Carlson Vol #: 161
EC 2390 Mr. Erik Kreider Vol #: 161
EC 2391 Ms. Tracie Beasley Vol #: 161
EC 2392 Ms. Dana Goldstein Vol #: 161
EC 2393 Miss. Molly Hale Vol #: 161
EC 2394 Mr. S K Vol #: 161
EC 2395 Mrs. Kedrann Hill Vol #: 161
EC 2396 Mrs. Suzanne Maddox Vol #: 161
EC 2397 Ms. Trish Smith Vol #: 161
EC 2398 Mrs. mrtha coonley Vol #: 161
EC 2399 Ms. Anja Schiller Vol #: 161
EC 2400 Mr. Sid Fincher Vol #: 161
EC 2401 Mrs. LeeAnn Carrow Vol #: 161
EC 2402 Mrs. Jackie VanBrocklin Vol #: 161
EC 2403 Mrs. Elly Hereth Vol #: 161
EC 2404 Ms. Katie Wehr Vol #: 161
EC 2405 Mrs. Susan Redding Vol #: 161
EC 2406 Mr. Michael Cannella Vol #: 161
EC 2407 Mrs. Lori Robinson Vol #: 161
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 20740 NOW Foods Vol #: 181
LET 20741 PHI-TEN USA, INC. Vol #: 181
LET 20742 PHI-TEN USA, INC. Vol #: 181
LET 20743 PHI-TEN USA, INC. Vol #: 181
LET 20744 NOW Foods Vol #: 181
LET 20745 NOW Foods Vol #: 181
LET 20746 NOW Foods Vol #: 181
LET 20747 NOW Foods Vol #: 181
LET 20748 NOW Foods Vol #: 181
LET 20749 NOW Foods Vol #: 181
LET 20750 NOW Foods Vol #: 181
LET 20751 NOW Foods Vol #: 181
LET 20752 NOW Foods Vol #: 181
LET 20753 NOW Foods Vol #: 181
LET 20754 NOW Foods Vol #: 181
LET 20755 NOW Foods Vol #: 181
LET 20756 NOW Foods Vol #: 181
LET 20757 NOW Foods Vol #: 181
LET 20758 NOW Foods Vol #: 181
LET 20759 NOW Foods Vol #: 181
LET 20760 NOW Foods Vol #: 181
LET 20761 NOW Foods Vol #: 181
LET 20762 NOW Foods Vol #: 181
LET 20763 NOW Foods Vol #: 181
LET 20764 NOW Foods Vol #: 181
LET 20765 NOW Foods Vol #: 181
LET 20766 NOW Foods Vol #: 181
LET 20767 NOW Foods Vol #: 181
LET 20768 NOW Foods Vol #: 181
LET 20769 NOW Foods Vol #: 181
LET 20770 NOW Foods Vol #: 181
1999D-2013 Cooperative Manufacturing Arrangements for Licensed
EC 1 Hollister-Stier Laboratories, LLC Vol #: 1
2004D-0002 Guidance for Industry and FDA Staff; Saline, Silicone Gel, and Alternative Breast Implants
EC 23 Ms. Tammi Raabe Vol #: 2
2006D-0347 Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays
NEC 2 FDA Vol #: 3
2006N-0454 Use of Ozone-Depleting Substances; Removal of Essential-Use Designations
C 2301 P Smith Vol #: 26
C 2302 S Davis Vol #: 26
C 2303 S Gribble Vol #: 26
C 2304 Pediatric Medicine of Wallingford Vol #: 26
C 2305 S Barnes Vol #: 26
C 2306 J Filippone Vol #: 26
C 2307 L Wilkerson Vol #: 26
C 2308 M Hartlage Vol #: 26
C 2309 D Stoterau Vol #: 26
C 2310 R Adolph Vol #: 26
C 2311 M Murray Vol #: 26
C 2312 M Clay Vol #: 26
C 2313 A Baker Vol #: 26
C 2314 H Tolmas Vol #: 26
C 2315 B Swaner Vol #: 26
C 2316 G Rater Vol #: 26
C 2317 A Marceau Vol #: 26
C 2318 B Vowels Vol #: 26
C 2319 K Ciske Vol #: 26
C 2320 L Jacobs Vol #: 26
C 2321 J Dorow Vol #: 26
C 2322 A Cates Vol #: 26
C 2323 A Hickey Vol #: 26
C 2324 C Stone Vol #: 26
C 2325 P Muzerolle Vol #: 26
C 2326 D Boyle Vol #: 26
C 2327 G Moore Vol #: 26
C 2328 J Bandreau Vol #: 26
C 2329 D Bogue Vol #: 26
C 2330 J Duncan Vol #: 26
C 2331 L Hagen Vol #: 26
C 2332 V Wright Vol #: 26
C 2333 K Berry Vol #: 26
C 2334 R Luttrell Vol #: 26
C 2335 S Carson Vol #: 26
C 2336 I Peters Vol #: 26
C 2337 W Fisher Vol #: 26
C 2338 V Bowles Vol #: 26
C 2339 J Rocha Vol #: 26
C 2340 R Thompson Vol #: 26
C 2341 P Denoma Vol #: 26
C 2342 D Kilpatrich Vol #: 26
C 2343 N Burns Vol #: 26
C 2344 H DeYoung Vol #: 26
C 2345 R Quick Vol #: 26
C 2346 B W Stufflebam Vol #: 26
C 2347 B Ohlau Vol #: 26
C 2348 B Kinsey Vol #: 26
C 2349 B Ezell Vol #: 26
C 2350 J Bragg Vol #: 26
C 2351 B Beck Vol #: 26
C 2352 M Clark Vol #: 26
C 2353 L Nichrent Vol #: 26
C 2354 C Jones Vol #: 26
C 2355 O Schlabach Vol #: 26
C 2356 F W Forster Vol #: 26
C 2357 H Robert Vol #: 26
C 2358 G Havens Vol #: 26
C 2359 E Ludwick Vol #: 26
C 2360 T McCue Vol #: 26
C 2361 E Kray Vol #: 26
C 2362 H Mitchell Vol #: 26
C 2363 N Mann Vol #: 26
C 2364 J Kilpatrick Vol #: 26
C 2365 J Gophart Vol #: 26
C 2366 J Jerbic Vol #: 26
C 2367 E Evans Vol #: 26
C 2368 A Deines Vol #: 26
C 2369 T Huhn Vol #: 26
C 2370 J Bushirk Vol #: 26
C 2371 W Martiny Vol #: 26
C 2372 G Reeker Vol #: 26
C 2373 D Hashman Vol #: 26
C 2374 D Spencer Vol #: 26
C 2375 F Deibler Vol #: 26
C 2376 E Little Vol #: 26
C 2377 C Snyder Vol #: 26
C 2378 R Jirata Vol #: 26
C 2379 R Canup Vol #: 26
C 2380 J Hand Vol #: 26
C 2381 E Carberry Vol #: 26
C 2382 R Walker Vol #: 26
C 2383 M Rowe Vol #: 26
C 2384 B Smith Vol #: 26
C 2385 R McKernan Vol #: 26
C 2386 B Grandin Vol #: 26
C 2387 B. Phipps Vol #: 26
C 2388 L Butler Vol #: 26
C 2389 B Sims Vol #: 26
C 2390 D Anderson Vol #: 26
C 2391 E Keith Vol #: 26
C 2392 D Steiner Vol #: 26
C 2393 E Yawn Vol #: 26
C 2394 S Morris Vol #: 26
C 2395 L Conrad Vol #: 26
C 2396 A Nelson Vol #: 26
C 2397 M Halamicek Vol #: 26
C 2398 D Shaffer Vol #: 26
C 2399 J McNevin Vol #: 26
C 2400 M Adams Vol #: 26
C 2401 D Vlahovic Vol #: 26
C 2402 R Gates Vol #: 26
C 2403 W Shea Vol #: 26
C 2404 H Lighty Vol #: 26
C 2405 D Sprouse Vol #: 26
C 2406 R Rogers Vol #: 26
C 2407 S Barlter Vol #: 26
C 2408 D Williams Vol #: 26
C 2409 A Weissman Vol #: 26
C 2410 D Zemann Vol #: 26
C 2411 M Moore Vol #: 26
C 2412 N Berry Vol #: 26
C 2413 P Kennison Vol #: 26
C 2414 J Macaluso Vol #: 26
C 2415 S Frazier Vol #: 26
C 2416 J Philhower Vol #: 26
C 2417 P Thomas Vol #: 26
C 2418 J Claflin Vol #: 26
C 2419 D Phillips Vol #: 26
C 2420 S Bloch Vol #: 26
C 2421 M Shields Vol #: 26
C 2422 W Vowles Vol #: 26
2006P-0487 Health Claim Petition: Isomaltulose and Dental Caries
BKG 1 Background Vol #: 2
NIR 1 FDA Vol #: 1
2007D-0201 Guidance for Industry and Food and Drug Administration Staff; Premarket Notification (510(k)) Submissions for Medical Devices That Include Antimicrobial Agents
EC 2 Mr. gregory pinchinat Vol #: 1
2007D-0223 Guidance for Industry on Use of the Computer Crossmatch
EC 4 AABB Vol #: 1
EC 5 CMS Vol #: 1
2007D-0233 Guidance for Industry on Integrated Summaries of Effectiveness and Safety: Location Within the Common Technical Document
EC 3 Schering-Plough Vol #: 1
EC 4 Merck Research Laboratories Vol #: 1
EC 5 Pfizer Inc Vol #: 1
2007D-0268 Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Poly(hydroxybutyrate) Surgical Suture Produced by Recombinant DNA Technology
EC 7 Miss. Emma Rohrbach Vol #: 1
2007N-0179 Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges; Public Workshop
TR 1 Transcript of 6/25/07 Vol #: 3
TR 2 Transcript of 6/26/07 Vol #: 4
2007N-0186 Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary
NEC 1 FDA Vol #: 1
2007N-0231 Agency Information Collection Activities; Proposed Collection; Comment Request; Pre-market Approval of Medical Devices
N 2 FDA Vol #: 1
2007N-0277 Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Public Hearing
EC 17 Ms. Kelly Bowling Vol #: 1
EC 18 University of Wisconsin-Madison Vol #: 1
EC 19 Salt Institute Vol #: 1
EC 20 Mr. Chad Larson Vol #: 1
2007P-0282 Require all products labels to include this information: Products % Costs Packaging: 80% Content: 20%
EC 29 Plattsburgh State University Vol #: 1
EC 30 Ms. Sheila Braun Vol #: 1
EC 31 Retired Vol #: 1
EC 32 Mr. Owen Brady Vol #: 1
EC 33 University of Vermont Vol #: 1
EC 34 The University of Vermont Vol #: 1
EC 35 Mr. Dan Harvey Vol #: 1
EC 36 University of Vermont Vol #: 1
EC 37 UVM Vol #: 1
EC 38 home Vol #: 1
EC 39 Mrs. Linda Corse Vol #: 1
EC 40 Dr. Josh Bongard Vol #: 1
EC 41 Mrs. Treya Palmer Vol #: 1
EC 42 Mr. Willard Sawma Vol #: 1
EC 43 Mrs. Samantha Balmes Vol #: 1
EC 44 Vermont Law School Vol #: 1
EC 45 Mrs. Lydia Fiedler Vol #: 1
EC 46 Animal Answers Vol #: 1
EC 47 individual Vol #: 1
EC 48 Ms. Keri Toksu Vol #: 1
EC 49 Mt. Aberham Union High School Vol #: 1
EC 50 University of Vermont Vol #: 1
EC 51 Ms. Clara Bond Vol #: 1
EC 52 Mr. Winfield Carlough Vol #: 1
EC 53 Mr. Travis Gang Vol #: 1
EC 54 concerned citizen Vol #: 1
EC 55 Dr. William Stickney Vol #: 1
EC 56 n/a Vol #: 1
EC 57 Ms. Barbara Mines Vol #: 1
EC 58 Mr. Kevin Wrenner Vol #: 1
EC 59 Mrs. Tamara Smith Vol #: 1
2007P-0297 Request to reconsider the failure to approve Provenge
EC 99 Mr. Jeffery Rhoads Vol #: 1
EC 100 Mr. kevin smallwood Vol #: 1

Page created on September 18, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management